Lerink Swann analyst Geoff Porges weighed in today with a few insights on Celgene Corporation (NASDAQ:CELG), following investor meeting with Celgene’s CFO Peter Kellogg and Investor Relations …
Leerink analyst Geoff Porges was out with a few insights on Gilead Sciences, Inc. (NASDAQ:GILD), after hosting an R&D deep dive call with Gilead’s Chief Scientific …
After joining Leerink Partners in November, analyst Geoff Porges reinitiated coverage yesterday on major healthcare stocks. Among the equities in focus are pharmaceutical giants Gilead Sciences, Inc.
